334 related articles for article (PubMed ID: 33000238)
1. Circular RNAs: Novel biomarkers for cervical, ovarian and endometrial cancer (Review).
Shi Y; He R; Yang Y; He Y; Shao K; Zhan L; Wei B
Oncol Rep; 2020 Nov; 44(5):1787-1798. PubMed ID: 33000238
[TBL] [Abstract][Full Text] [Related]
2. Circular RNAs and their emerging roles as diagnostic and prognostic biomarkers in ovarian cancer.
Sheng R; Li X; Wang Z; Wang X
Cancer Lett; 2020 Mar; 473():139-147. PubMed ID: 31904484
[TBL] [Abstract][Full Text] [Related]
3. Circular RNAs: A novel biomarker for cervical cancer.
Chaichian S; Shafabakhsh R; Mirhashemi SM; Moazzami B; Asemi Z
J Cell Physiol; 2020 Feb; 235(2):718-724. PubMed ID: 31240697
[TBL] [Abstract][Full Text] [Related]
4. Role of hsa‑miR‑105 during the pathogenesis of paclitaxel resistance and its clinical implication in ovarian cancer.
Li M; Zhang S; Ma Y; Yang Y; An R
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33846814
[TBL] [Abstract][Full Text] [Related]
5. Treatment Outcomes of Epithelial Ovarian Cancers Following Maximum Cytoreduction and Adjuvant Paclitaxel-Carboplatin Chemotherapy: Egyptian NCI Experience.
Nassar HR; Zeeneldin AA; Helal AM; Ismail YM; Elsayed AM; Elbassuiony MA; Moneer MM
Asian Pac J Cancer Prev; 2015; 16(16):7237-42. PubMed ID: 26514517
[TBL] [Abstract][Full Text] [Related]
6. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
Del Carmen MG; Rice LW
Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
[No Abstract] [Full Text] [Related]
7. Advances in circular RNAs and their role in glioma (Review).
Zhang Y; Lin X; Geng X; Shi L; Li Q; Liu F; Fang C; Wang H
Int J Oncol; 2020 Jul; 57(1):67-79. PubMed ID: 32319596
[TBL] [Abstract][Full Text] [Related]
8. Selecting new upfront regimens for advanced ovarian cancer with biomarker guidance.
Chan JK; Liang SY; Kapp DS; Chan JE; Herzog TJ; Coleman RL; Monk BJ; Richardson MT
Gynecol Oncol; 2020 Dec; 159(3):604-606. PubMed ID: 32994055
[No Abstract] [Full Text] [Related]
9. Oncodiagnosis Panel: 2006. Ovarian, cervical, and endometrial cancer.
Viswanathan AN; Buttin BM; Kennedy AM
Radiographics; 2008; 28(1):289-307. PubMed ID: 18444279
[No Abstract] [Full Text] [Related]
10. Circular RNAs as emerging players in cervical cancer tumorigenesis; A review to roles and biomarker potentials.
Najafi S
Int J Biol Macromol; 2022 May; 206():939-953. PubMed ID: 35318084
[TBL] [Abstract][Full Text] [Related]
11. Dysregulated expression of circular RNAs serve as diagnostic and prognostic markers in ovarian and cervical cancer: A PRISMA-compliant systematic review and meta-analysis.
Liu F; Wu X; Zhu H; Wang F
Medicine (Baltimore); 2021 Oct; 100(39):e27352. PubMed ID: 34596142
[TBL] [Abstract][Full Text] [Related]
12. Carboplatin (every 21 days) and divided-dose paclitaxel (days 1, 11): rationale and tolerance in chemotherapy naïve women with high-grade epithelial cancers of Mullerian origin.
Kudlowitz D; Velastegui A; Musa F; Muggia F
Cancer Chemother Pharmacol; 2018 May; 81(5):847-851. PubMed ID: 29516152
[TBL] [Abstract][Full Text] [Related]
13. The feasibility of detecting endometrial and ovarian cancer using DNA methylation biomarkers in cervical scrapings.
Chang CC; Wang HC; Liao YP; Chen YC; Weng YC; Yu MH; Lai HC
J Gynecol Oncol; 2018 Jan; 29(1):e17. PubMed ID: 29185275
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of extensive cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with advanced epithelial ovarian cancer.
Ansaloni L; Agnoletti V; Amadori A; Catena F; Cavaliere D; Coccolini F; De Iaco P; Di Battista M; Framarini M; Gazzotti F; Ghermandi C; Kopf B; Saponara M; Tauceri F; Vallicelli C; Verdecchia GM; Pinna AD
Int J Gynecol Cancer; 2012 Jun; 22(5):778-85. PubMed ID: 22572845
[TBL] [Abstract][Full Text] [Related]
15. Hematologic markers of distant metastases and poor prognosis in gynecological cancers.
Abu-Shawer O; Abu-Shawer M; Hirmas N; Alhouri A; Massad A; Alsibai B; Sultan H; Hammo H; Souleiman M; Shebli Y; Al-Hussaini M
BMC Cancer; 2019 Feb; 19(1):141. PubMed ID: 30755184
[TBL] [Abstract][Full Text] [Related]
16. Preliminary experience with locoregional intraarterial chemotherapy of uterine cervical or endometrial cancer using the peripheral implantable port system (PIPS): a feasibility study.
Strecker EP; Heber R; Boos I; Göttmann D; Heinrich D
Cardiovasc Intervent Radiol; 2003; 26(2):118-22. PubMed ID: 12616415
[TBL] [Abstract][Full Text] [Related]
17. Circular RNAs in endometrial carcinoma (Review).
Gao S; Zhao T; Meng F; Luo Y; Li Y; Wang Y
Oncol Rep; 2022 Dec; 48(6):. PubMed ID: 36263622
[TBL] [Abstract][Full Text] [Related]
18. Novel Surgical Strategies in the Treatment of Gynecological Malignancies.
Angeles MA; Martínez-Gómez C; Migliorelli F; Voglimacci M; Figurelli J; Motton S; Tanguy Le Gac Y; Ferron G; Martinez A
Curr Treat Options Oncol; 2018 Nov; 19(12):73. PubMed ID: 30411170
[TBL] [Abstract][Full Text] [Related]
19. Riddle of the Sphinx: Emerging role of circular RNAs in cervical cancer.
Yin C; Yu J; Liu G; He J; Wu P
Pathol Res Pract; 2024 May; 257():155315. PubMed ID: 38653090
[TBL] [Abstract][Full Text] [Related]
20. The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.
Najafi S
J Cancer Res Clin Oncol; 2023 May; 149(5):2211-2234. PubMed ID: 36053324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
